An open and multi-center study was conducted in type 2 diabetic patients to re-evaluate the efficacy and adverse effects for domestic repaglinide treatment.

• 采用多中心、开放性临床试验,观察国产瑞格列奈上市后治疗2型糖尿病的有效性和安全性。